Sandra Pérez-Rial
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sandra Pérez-Rial has a total of 124 co-authors. Here are the top co-authors by number of shared publications:
Germán Peces-Barba
Affiliation Respiratory Research Unit, Health Research Institute–Fundación Jimenez Diaz University Hospital, Madrid, Spain
12 shared publications- Jorge Manzanares
Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, Avda. de Ramón y Cajal s/n, San Juan de Alicante, 03550 Alicante, Spain
9 shared publications Nicolás González-Mangado
Respiratory Research Unit, Biomedical Research Institute—Fundación Jiménez Díaz, Madrid, Spain
8 shared publicationsLaura del Puerto-Nevado
Respiratory Research Group, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz-CIBERES (IIS-FJD-CIBERES), Madrid, Spain
6 shared publications- Jesús Ruiz-Cabello
Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Spain
4 shared publications José M. Oliva
Section of Molecular Neuropharmacology and Centre for Behavioral Phenotyping, Department of Physiology and Pharmacology, Karolinska Institute, S-171 77 Stockholm, Sweden
4 shared publications
Latest Publications
- Open Access
Circulating microRNAs as potential biomarkers of hypertrophic cardiomyopathy phenotypic expression
Background Hypertrophic cardiomyopathy (HCM) is characterized by significant variability in clinical presentation among patients with similar genetic backgrounds. The role of microRNAs (miRNAs) as epigenetic regulators in HCM remains underexplored. This pilot study aims to identify and characterize circulating miRNAs associated with different HCM phenotypes. A cross-sectional study was conducted involving 28 participants: 10 with aggressive HCM, 10 with soft HCM, and 8 age- and sex-matched healthy controls. Circulating miRNAs were profiled using next-generation sequencing and quantitative real-time PCR. Differential expression analysis was performed to identify miRNAs associated with the aggressive phenotype. Results miR-16-5p, miR-17-5p, and let-7f-5p were identified as miRNAs significantly upregulated in the aggressive phenotype group compared to soft phenotypes and healthy controls. ROC analysis demonstrated statistically significant differences between aggressive HCM and softer forms with an area under the curve: miR-16-5p 0.833 (0.614 - 1), miR-17-5p 0.859 (0.648 – 1.00) and let-7f-5p 0.825 (0.62 – 1.00). After performing a target prediction analysis for the three miRNAs, the results were validated with three human transcriptomic datasets from control vs HCM patients. The analysis identified 34 quadruple coincidences across the four analyzed groups, and the enrichment analysis highlighted the hypoxia-inducible factor-1 (HIF-1) pathway. Conclusions miR-16-5p, miR-17-5p, and let-7f-5p appear to play a role in modulating the phenotypic expression of HCM. The potential use of these miRNAs as biomarkers for risk stratification and therapeutic targets to intervene in disease progression is promising. Validation in a wide clinical cohort is necessary to further elucidate the underlying mechanisms and therapeutic implications of miRNA dysregulation in HCM.
Open AccessCirculating microRNAs as potential biomarkers of hypertrophic cardiomyopathy phenotypic expression
Background Hypertrophic cardiomyopathy (HCM) is characterized by significant variability in clinical presentation among patients with similar genetic backgrounds. The role of microRNAs (miRNAs) as epigenetic regulators in HCM remains underexplored. This pilot study aims to identify and characterize circulating miRNAs associated with different HCM phenotypes. A cross-sectional study was conducted involving 28 participants: 10 with aggressive HCM, 10 with soft HCM, and 8 age- and sex-matched healthy controls. Circulating miRNAs were profiled using next-generation sequencing and quantitative real-time PCR. Differential expression analysis was performed to identify miRNAs associated with the aggressive phenotype. Results miR-16-5p, miR-17-5p, and let-7f-5p were identified as miRNAs significantly upregulated in the aggressive phenotype group compared to soft phenotypes and healthy controls. ROC analysis demonstrated statistically significant differences between aggressive HCM and softer forms with an area under the curve: miR-16-5p 0.833 (0.614 - 1), miR-17-5p 0.859 (0.648 – 1.00) and let-7f-5p 0.825 (0.62 – 1.00). After performing a target prediction analysis for the three miRNAs, the results were validated with three human transcriptomic datasets from control vs HCM patients. The analysis identified 34 quadruple coincidences across the four analyzed groups, and the enrichment analysis highlighted the hypoxia-inducible factor-1 (HIF-1) pathway. Conclusions miR-16-5p, miR-17-5p, and let-7f-5p appear to play a role in modulating the phenotypic expression of HCM. The potential use of these miRNAs as biomarkers for risk stratification and therapeutic targets to intervene in disease progression is promising. Validation in a wide clinical cohort is necessary to further elucidate the underlying mechanisms and therapeutic implications of miRNA dysregulation in HCM.
- Open Access
- 22 August 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (8) , e0309166
Differential lung gene expression identified Zscan2 and Bag6 as novel tissue repair players in an experimental COPD model
Chronic obstructive pulmonary disease is a common chronic lung disease with an ever-increasing incidence. Despite years of drug research and approvals, we are still not able to halt progress or restore normal lung function. Our previous studies have demonstrated that liver growth factor—LGF has an effect on the repair of the affected tissue in a mouse model of cigarette smoke exposure, but by what pathways it achieves this is unknown. The present study aimed to identify differentially expressed genes between emphysematous mice treated with LGF to identify potential therapeutic targets for the treatment of pulmonary emphysema. The emphysema mouse model was induced by prolonged exposure to cigarette smoke. To determine the gene expression profile of the lung in smokers treated or not with LGF, lung messenger RNA gene expression was assessed with the Agilent Array platform. We carried out differentially expressed gene analysis, functional enrichment and validated in treated mouse lung samples. The treated group significantly improved lung function (~35%) and emphysema level (~20%), consistent with our previous published studies. Microarray analysis demonstrated 290 differentially expressed genes in total (2.0-fold over or lower expressed). Injury repair-associated genes and pathways were further enhanced in the lung of LGF treated mice. The expression trends of two genes (Zscan2 and Bag6) were different in emphysematous lungs treated with LGF compared to untreated lungs. Therefore, Zscan2 and Bag6 genes could play a role in regulating inflammation and the immune response in the lung that undergoes partial lung regeneration. However, further studies are necessary to demonstrate this causal relationship.
- 22 August 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (8) , e0309166
Open AccessDifferential lung gene expression identified Zscan2 and Bag6 as novel tissue repair players in an experimental COPD model
Chronic obstructive pulmonary disease is a common chronic lung disease with an ever-increasing incidence. Despite years of drug research and approvals, we are still not able to halt progress or restore normal lung function. Our previous studies have demonstrated that liver growth factor—LGF has an effect on the repair of the affected tissue in a mouse model of cigarette smoke exposure, but by what pathways it achieves this is unknown. The present study aimed to identify differentially expressed genes between emphysematous mice treated with LGF to identify potential therapeutic targets for the treatment of pulmonary emphysema. The emphysema mouse model was induced by prolonged exposure to cigarette smoke. To determine the gene expression profile of the lung in smokers treated or not with LGF, lung messenger RNA gene expression was assessed with the Agilent Array platform. We carried out differentially expressed gene analysis, functional enrichment and validated in treated mouse lung samples. The treated group significantly improved lung function (~35%) and emphysema level (~20%), consistent with our previous published studies. Microarray analysis demonstrated 290 differentially expressed genes in total (2.0-fold over or lower expressed). Injury repair-associated genes and pathways were further enhanced in the lung of LGF treated mice. The expression trends of two genes (Zscan2 and Bag6) were different in emphysematous lungs treated with LGF compared to untreated lungs. Therefore, Zscan2 and Bag6 genes could play a role in regulating inflammation and the immune response in the lung that undergoes partial lung regeneration. However, further studies are necessary to demonstrate this causal relationship.
- Open Access
- 21 August 2023
- Published by Springer Nature in Research Square
Lung gene expression study identifying Zscan2 and Bag6 as novel tissue repair players in an experimental model of COPD
Background Chronic obstructive pulmonary disease (COPD) is a common chronic lung disease with an ever-increasing incidence. Despite years of drug research and approvals, we are still not able to halt progress or restore normal lung function. Our previous studies have demonstrated that liver growth factor (LGF) has an effect on the repair of the affected tissue in a mouse model of cigarette smoke exposure (CSE), but by what pathways it achieves this is unknown. The present study aimed to identify differentially expressed genes (DEGs) between emphysematous mice treated with LGF to identify potential biomarkers for the treatment of pulmonary emphysema. Methods The emphysema mouse model was induced by prolonged exposure to cigarette smoke. To determine the gene expression profile of the lung in smokers treated or not with LGF, lung messenger RNA (mRNA) gene expression was assessed with the Agilent Array platform and validated in mouse lung samples. Results The treated group significantly improved lung function (~ 35%) and emphysema level (~ 20%). Microarray analysis demonstrated a total of 290 DEGs (1.5-fold up- or downregulated). The expression trends of 2 genes (Zscan2 and Bag6) were different in emphysematous lungs treated with LGF compared to untreated lungs. Conclusions Therefore, Zscan2 and Bag6 could play a role in regulating inflammation and the immune response in the lung that undergoes partial lung regeneration.
- 21 August 2023
- Published by Springer Nature in Research Square
Open AccessLung gene expression study identifying Zscan2 and Bag6 as novel tissue repair players in an experimental model of COPD
Background Chronic obstructive pulmonary disease (COPD) is a common chronic lung disease with an ever-increasing incidence. Despite years of drug research and approvals, we are still not able to halt progress or restore normal lung function. Our previous studies have demonstrated that liver growth factor (LGF) has an effect on the repair of the affected tissue in a mouse model of cigarette smoke exposure (CSE), but by what pathways it achieves this is unknown. The present study aimed to identify differentially expressed genes (DEGs) between emphysematous mice treated with LGF to identify potential biomarkers for the treatment of pulmonary emphysema. Methods The emphysema mouse model was induced by prolonged exposure to cigarette smoke. To determine the gene expression profile of the lung in smokers treated or not with LGF, lung messenger RNA (mRNA) gene expression was assessed with the Agilent Array platform and validated in mouse lung samples. Results The treated group significantly improved lung function (~ 35%) and emphysema level (~ 20%). Microarray analysis demonstrated a total of 290 DEGs (1.5-fold up- or downregulated). The expression trends of 2 genes (Zscan2 and Bag6) were different in emphysematous lungs treated with LGF compared to untreated lungs. Conclusions Therefore, Zscan2 and Bag6 could play a role in regulating inflammation and the immune response in the lung that undergoes partial lung regeneration.
- Open Access
- 3 December 2021
- Published by MDPI AG in Antibiotics
- Vol. 10 (12) , 1481
Sanguiin H-6 Fractionated from Cloudberry (Rubus chamaemorus) Seeds Can Prevent the Methicillin-Resistant Staphylococcus aureus Biofilm Development during Wound Infection
Staphylococcus aureus is the most common cause of surgical site infections and its treatment is challenging due to the emergence of multi-drug resistant strains such as methicillin-resistant S. aureus (MRSA). Natural berry-derived compounds have shown antimicrobial potential, e.g., ellagitannins such as sanguiin H-6 and lambertianin C, the main phenolic compounds in Rubus seeds, have shown antimicrobial activity. The aim of this study was to evaluate the effect of sanguiin H-6 and lambertianin C fractionated from cloudberry seeds, on the MRSA growth, and as treatment of a MRSA biofilm development in different growth media in vitro and in vivo by using a murine wound infection model where sanguiin H-6 and lambertianin C were used to prevent the MRSA infection. Sanguiin H-6 and lambertianin C inhibited the in vitro biofilm development and growth of MRSA. Furthermore, sanguiin H-6 showed significant anti-MRSA effect in the in vivo wound model. Our study shows the possible use of sanguiin H-6 as a preventive measure in surgical sites to avoid postoperative infections, whilst lambertianin C showed no anti-MRSA activity.
- 3 December 2021
- Published by MDPI AG in Antibiotics
- Vol. 10 (12) , 1481
Open AccessSanguiin H-6 Fractionated from Cloudberry (Rubus chamaemorus) Seeds Can Prevent the Methicillin-Resistant Staphylococcus aureus Biofilm Development during Wound Infection
Staphylococcus aureus is the most common cause of surgical site infections and its treatment is challenging due to the emergence of multi-drug resistant strains such as methicillin-resistant S. aureus (MRSA). Natural berry-derived compounds have shown antimicrobial potential, e.g., ellagitannins such as sanguiin H-6 and lambertianin C, the main phenolic compounds in Rubus seeds, have shown antimicrobial activity. The aim of this study was to evaluate the effect of sanguiin H-6 and lambertianin C fractionated from cloudberry seeds, on the MRSA growth, and as treatment of a MRSA biofilm development in different growth media in vitro and in vivo by using a murine wound infection model where sanguiin H-6 and lambertianin C were used to prevent the MRSA infection. Sanguiin H-6 and lambertianin C inhibited the in vitro biofilm development and growth of MRSA. Furthermore, sanguiin H-6 showed significant anti-MRSA effect in the in vivo wound model. Our study shows the possible use of sanguiin H-6 as a preventive measure in surgical sites to avoid postoperative infections, whilst lambertianin C showed no anti-MRSA activity.
- Open Access
- 22 June 2020
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (6) , e0234606
Early detection of skeletal muscle bioenergetic deficit by magnetic resonance spectroscopy in cigarette smoke-exposed mice
Skeletal muscle dysfunction is a common complication and an important prognostic factor in patients with chronic obstructive pulmonary disease (COPD). It is associated with intrinsic muscular abnormalities of the lower extremities, but it is not known whether there is an easy way to predict its presence. Using a mouse model of chronic cigarette smoke exposure, we tested the hypothesis that magnetic resonance spectroscopy allows us to detect muscle bioenergetic deficit in early stages of lung disease. We employed this technique to evaluate the synthesis rate of adenosine triphosphate (ATP) and characterize concomitant mitochondrial dynamics patterns in the gastrocnemius muscle of emphysematous mice. The fibers type composition and citrate synthase (CtS) and cytochrome c oxidase subunit IV (COX4) enzymatic activities were evaluated. We found that the rate of ATP synthesis was reduced in the distal skeletal muscle of mice exposed to cigarette smoke. Emphysematous mice showed a significant reduction in body weight gain, in the cross-sectional area of the total fiber and in the COX4 to CtS activity ratio, due to a significant increase in CtS activity of the gastrocnemius muscle. Taken together, these data support the hypothesis that in the early stage of lung disease, we can detect a decrease in ATP synthesis in skeletal muscle, partly caused by high oxidative mitochondrial enzyme activity. These findings may be relevant to predict the presence of skeletal bioenergetic deficit in the early stage of lung disease besides placing the mitochondria as a potential therapeutic target for the treatment of COPD comorbidities.
- 22 June 2020
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (6) , e0234606
Open AccessEarly detection of skeletal muscle bioenergetic deficit by magnetic resonance spectroscopy in cigarette smoke-exposed mice
Skeletal muscle dysfunction is a common complication and an important prognostic factor in patients with chronic obstructive pulmonary disease (COPD). It is associated with intrinsic muscular abnormalities of the lower extremities, but it is not known whether there is an easy way to predict its presence. Using a mouse model of chronic cigarette smoke exposure, we tested the hypothesis that magnetic resonance spectroscopy allows us to detect muscle bioenergetic deficit in early stages of lung disease. We employed this technique to evaluate the synthesis rate of adenosine triphosphate (ATP) and characterize concomitant mitochondrial dynamics patterns in the gastrocnemius muscle of emphysematous mice. The fibers type composition and citrate synthase (CtS) and cytochrome c oxidase subunit IV (COX4) enzymatic activities were evaluated. We found that the rate of ATP synthesis was reduced in the distal skeletal muscle of mice exposed to cigarette smoke. Emphysematous mice showed a significant reduction in body weight gain, in the cross-sectional area of the total fiber and in the COX4 to CtS activity ratio, due to a significant increase in CtS activity of the gastrocnemius muscle. Taken together, these data support the hypothesis that in the early stage of lung disease, we can detect a decrease in ATP synthesis in skeletal muscle, partly caused by high oxidative mitochondrial enzyme activity. These findings may be relevant to predict the presence of skeletal bioenergetic deficit in the early stage of lung disease besides placing the mitochondria as a potential therapeutic target for the treatment of COPD comorbidities.
- 28 September 2019
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 54 (suppl 63) , PA2433
Early detection of skeletal muscle bioenergetic deficit by non invasive 31-phosphorus magnetic resonance spectroscopy in mice exposed to cigarette smoke
Skeletal muscle dysfunction is a common feature in COPD which is associated with intrinsic muscular abnormalities, but it is not known whether there is an easy way of predicting their presence in early stage of disease. Using a mouse model of cigarette smoke exposure, we tested the hypothesis that 31-phosphorus magnetic resonance spectroscopy allows us to early detect skeletal muscle bioenergetic deficit. We employed this technique to assess the rate of ATP synthesis, and characterized the concomitant mitochondrial dynamics patterns in skeletal. We specifically explored whether experimental COPD model may alter mitochondrial respiratory chain complexes in peripheral muscles. We evaluated citrate synthase (CtS) and cytochrome c oxidase (COX) enzyme activities in gastrocnemius of mice. We found that rate of muscle ATP synthesis was reduced in skeletal muscle of mice exposed to cigarette smoke. Furthermore, ATP synthesis rate was directly related to mitochondrial enzyme activity. Emphysematous mice showed a significant reduction in body weight gain and decreased activity of CtS/COX. Taken together, these data support the hypothesis that in early stage of lung disease we are able to detect a decreased skeletal muscle ATP synthesis, in part caused by low mitochondrial enzyme activity. These findings may prove relevant to predict the skeletal bioenergetic deficit presence in the early stage of the lung disease and thus be able to act preventively in the evolution of the disease, besides placing mitochondria as potential therapeutic target for the treatment of COPD comorbidities.
- 28 September 2019
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 54 (suppl 63) , PA2433
Early detection of skeletal muscle bioenergetic deficit by non invasive 31-phosphorus magnetic resonance spectroscopy in mice exposed to cigarette smoke
Skeletal muscle dysfunction is a common feature in COPD which is associated with intrinsic muscular abnormalities, but it is not known whether there is an easy way of predicting their presence in early stage of disease. Using a mouse model of cigarette smoke exposure, we tested the hypothesis that 31-phosphorus magnetic resonance spectroscopy allows us to early detect skeletal muscle bioenergetic deficit. We employed this technique to assess the rate of ATP synthesis, and characterized the concomitant mitochondrial dynamics patterns in skeletal. We specifically explored whether experimental COPD model may alter mitochondrial respiratory chain complexes in peripheral muscles. We evaluated citrate synthase (CtS) and cytochrome c oxidase (COX) enzyme activities in gastrocnemius of mice. We found that rate of muscle ATP synthesis was reduced in skeletal muscle of mice exposed to cigarette smoke. Furthermore, ATP synthesis rate was directly related to mitochondrial enzyme activity. Emphysematous mice showed a significant reduction in body weight gain and decreased activity of CtS/COX. Taken together, these data support the hypothesis that in early stage of lung disease we are able to detect a decreased skeletal muscle ATP synthesis, in part caused by low mitochondrial enzyme activity. These findings may prove relevant to predict the skeletal bioenergetic deficit presence in the early stage of the lung disease and thus be able to act preventively in the evolution of the disease, besides placing mitochondria as potential therapeutic target for the treatment of COPD comorbidities.
- 1 February 2019
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 55 (2) , 65-66
Do Experimental COPD Models Make Sense?
- 1 February 2019
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 55 (2) , 65-66
Do Experimental COPD Models Make Sense?
- 15 October 2016
- Published by Springer Nature in Molecular Neurobiology
- Vol. 54 (9) , 6737-6749
TGFβ Contributes to the Anti-inflammatory Effects of Tauroursodeoxycholic Acid on an Animal Model of Acute Neuroinflammation
The bile acid conjugate tauroursodeoxycholic acid (TUDCA) is a neuroprotective agent in various animal models of neuropathologies. We have previously shown the anti-inflammatory properties of TUDCA in an animal model of acute neuroinflammation. Here, we present a new anti-inflammatory mechanism of TUDCA through the regulation of transforming growth factor β (TGFβ) pathway. The bacterial lipopolysaccharide (LPS) was injected intravenously (iv) on TGFβ reporter mice (Smad-binding element (SBE)/Tk-Luc) to study in their brains the real-time activation profile of the TGFβ pathway in a non-invasive way. The activation of the TGFβ pathway in the brain of SBE/Tk-Luc mice increased 24 h after LPS injection, compared to control animals. This activation peak increased further in mice treated with both LPS and TUDCA than in mice treated with LPS only. The enhanced TGFβ activation in mice treated with LPS and TUDCA correlated with both an increase in TGFβ3 transcript in mouse brain and an increase in TGFβ3 immunoreactivity in microglia/macrophages, endothelial cells, and neurons. Inhibition of the TGFβ receptor with SB431542 drug reverted the effect of TUDCA on microglia/macrophages activation and on TGFβ3 immunoreactivity. Under inflammatory conditions, treatment with TUDCA enhanced further the activation of TGFβ pathway in mouse brain and increased the expression of TGFβ3. Therefore, the induction of TGFβ3 by TUDCA might act as a positive feedback, increasing the initial activation of the TGFβ pathway by the inflammatory stimulus. Our findings provide proof-of-concept that TGFβ contributes to the anti-inflammatory effect of TUDCA under neuroinflammatory conditions.
- 15 October 2016
- Published by Springer Nature in Molecular Neurobiology
- Vol. 54 (9) , 6737-6749
TGFβ Contributes to the Anti-inflammatory Effects of Tauroursodeoxycholic Acid on an Animal Model of Acute Neuroinflammation
The bile acid conjugate tauroursodeoxycholic acid (TUDCA) is a neuroprotective agent in various animal models of neuropathologies. We have previously shown the anti-inflammatory properties of TUDCA in an animal model of acute neuroinflammation. Here, we present a new anti-inflammatory mechanism of TUDCA through the regulation of transforming growth factor β (TGFβ) pathway. The bacterial lipopolysaccharide (LPS) was injected intravenously (iv) on TGFβ reporter mice (Smad-binding element (SBE)/Tk-Luc) to study in their brains the real-time activation profile of the TGFβ pathway in a non-invasive way. The activation of the TGFβ pathway in the brain of SBE/Tk-Luc mice increased 24 h after LPS injection, compared to control animals. This activation peak increased further in mice treated with both LPS and TUDCA than in mice treated with LPS only. The enhanced TGFβ activation in mice treated with LPS and TUDCA correlated with both an increase in TGFβ3 transcript in mouse brain and an increase in TGFβ3 immunoreactivity in microglia/macrophages, endothelial cells, and neurons. Inhibition of the TGFβ receptor with SB431542 drug reverted the effect of TUDCA on microglia/macrophages activation and on TGFβ3 immunoreactivity. Under inflammatory conditions, treatment with TUDCA enhanced further the activation of TGFβ pathway in mouse brain and increased the expression of TGFβ3. Therefore, the induction of TGFβ3 by TUDCA might act as a positive feedback, increasing the initial activation of the TGFβ pathway by the inflammatory stimulus. Our findings provide proof-of-concept that TGFβ contributes to the anti-inflammatory effect of TUDCA under neuroinflammatory conditions.
- 1 March 2015
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 51 (3) , 121-127
Animal Models of Chronic Obstructive Pulmonary Disease
- 1 March 2015
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 51 (3) , 121-127
Animal Models of Chronic Obstructive Pulmonary Disease